|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
| Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2008 / October 2008 / October 6, 2008 Magic polypill for heart problems comes closer to reality |
How binge drinking drives heart disease
Lack of exercise put depressed heart patients at greater risk
How cancer prevention drives aging
For the first time, researchers have found how cellular senescence, the well-known mechanism for preventing cancer, can trigger aging and age-related disease by changing the local tissue environment. ANI
Scientists unveil genes vital to vital to adult heart function
In a study on fruit fly Drosophila, scientists at the Burnham Institute for Medical Research (Burnham) have found that genes involved in embryonic heart development are vital to adult heart function in both fruit flies and humans. ANI
Psychiatric disorders common among college-aged
A new study has revealed that psychiatric disorders appear to be common among 18- to 24-year-olds, with overall rates similar among those attending or not attending college. ANI
Tests on Indian generic drug company Dr Reddys new tablet, which can halve the risk of death due to heart attacks and stroke, have begun in London.
London, Oct 6 : Tests on Indian generic drug company Dr Reddy's new tablet, which can halve the risk of death due to heart attacks and stroke, have begun in London.
The once-a-day tablet called Red heart pill combines four different medicines - aspirin, a statin to lower cholesterol, and an ACE inhibitor and a thiazide to counter high blood pressure in one tablet, reports News Scientist.
The 12-week pilot trial includes seven hundred volunteers in six countries. If all goes well, the main trial with 5,000 to 7,000 volunteers will begin at the end of next year.
According to Simon Thom of Imperial College London, who is running the UK trials, the multi-drug polypill is aimed at reducing the risk of heart disease and stroke in poor and rich countries alike.
Thom said that there are particular groups who are not getting the required preventive therapy, both among those at modest cardiovascular risk who are not being evaluated and those at pretty serious risk who have already had a heart attack.
He said that the pill could be distributed to everyone over 55 in developing countries.
ANI
